HCPCS to NDC

HCPCS Code “q5158” To NDC Mapping Options

“q5158” To NDC Crosswalk(s)

Source HCPCS Code Target NDC Code
Q5158
Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg 		⇄ 65219-0668-01
CONEXXENCE 60 MG/ML SYRINGE
Detail Information
Relationship Start Date 01/01/2026
Relationship End Date 12/31/3999
Number Of Items In Ndc Package 1
Ndc Package Measure ML
Ndc Package Type SYRINGE
Route Of Administration SQ
Billing Units ML
Q5158
Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg 		⇄ 65219-0670-01
BOMYNTRA 120 MG/1.7 ML VIAL
Detail Information
Relationship Start Date 01/01/2026
Relationship End Date 12/31/3999
Number Of Items In Ndc Package 1.7
Ndc Package Measure ML
Ndc Package Type VIAL
Route Of Administration SQ
Billing Units ML
Q5158
Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg 		⇄ 65219-0672-01
BOMYNTRA 120 MG/1.7 ML SYRINGE
Detail Information
Relationship Start Date 01/01/2026
Relationship End Date 12/31/3999
Number Of Items In Ndc Package 1.7
Ndc Package Measure ML
Ndc Package Type SYRINGE
Route Of Administration SQ
Billing Units ML
Q5158
Inj, denosumab-bnht, 1 mg 		⇄ 65219-0668-01
Conexxence
Detail Information
Relationship Start Date
Relationship End Date
Number Of Items In Ndc Package
Ndc Package Measure
Ndc Package Type
Route Of Administration
Billing Units
Q5158
Inj, denosumab-bnht, 1 mg 		⇄ 65219-0670-01
Bomyntra
Detail Information
Relationship Start Date
Relationship End Date
Number Of Items In Ndc Package
Ndc Package Measure
Ndc Package Type
Route Of Administration
Billing Units
Q5158
Inj, denosumab-bnht, 1 mg 		⇄ 65219-0672-01
Bomyntra
Detail Information
Relationship Start Date
Relationship End Date
Number Of Items In Ndc Package
Ndc Package Measure
Ndc Package Type
Route Of Administration
Billing Units